rec27 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
rec27 antibody; mug41 antibody; SPBC577.05c antibody; Meiotic recombination protein rec27 antibody; Meiotically up-regulated gene 41 protein antibody
Target Names
rec27
Uniprot No.

Target Background

Function
Rec27 antibody is essential for accurate meiotic chromosome segregation and recombination.
Gene References Into Functions
  1. Rec27 antibody is a component of linear elements. PMID: 18514516
Database Links
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is rec27 and why is it significant in meiotic recombination research?

Rec27 is a protein that forms part of the MRR complex (Mug20-Rec25-Rec27) in Schizosaccharomyces pombe. This complex plays a crucial role in meiotic DNA double-strand break (DSB) formation, which is essential for proper chromosome segregation during meiosis. Rec27 is highly significant in research because it functions as the primary DNA-binding component within the MRR complex. Previous genetic research has demonstrated that Rec27 is indispensable for meiotic DSB formation, as mutants lacking functional Rec27 show significantly reduced recombination levels . The protein localizes to chromosome axes and appears to spatially and numerically control DSB formation by altering chromosome structure. When studying meiotic recombination mechanisms, antibodies against Rec27 provide valuable tools for tracking protein localization and interactions.

What are the key structural features of rec27 relevant to antibody development?

Rec27 contains several structurally and functionally important regions that are relevant targets for antibody development. Most notably, the protein contains a cluster of five basic amino acid residues (K28, R32, R33, K35, and K36) that are critical for its DNA binding activity . These positively charged residues form a DNA-interaction domain that is highly conserved among Schizosaccharomyces species. Antibodies targeting this region can be particularly useful for functional studies but may interfere with the protein's DNA binding capabilities in some experimental contexts. Additionally, Rec27 requires complex formation with Rec25 and Mug20 to function properly, suggesting the presence of protein-protein interaction domains that could serve as alternative antibody targets when preserving DNA binding function is essential .

How can researchers validate the specificity of rec27 antibodies?

When validating rec27 antibodies, researchers should follow these methodological steps:

  • Cell line or tissue validation: Use fission yeast strains with known Rec27 expression levels, including wild-type and rec27 deletion mutants, to verify antibody specificity .

  • Subcellular localization confirmation: Verify that the antibody detects Rec27 at the expected chromosomal locations during meiotic prophase .

  • RNAi or CRISPR confirmation: Use rec27 knockdown or knockout models to confirm reduced or absent signal with the antibody .

  • Protein overexpression testing: Test antibody response in systems overexpressing tagged or untagged Rec27 .

  • Immunoprecipitation followed by mass spectrometry: Confirm that the antibody pulls down genuine Rec27 protein by analyzing the immunoprecipitated products.

  • Cross-reactivity assessment: Test the antibody against related proteins, particularly Rec25 and Mug20, to ensure specificity within the MRR complex .

Stringent testing with these approaches ensures the antibody specifically recognizes Rec27 and not related proteins or non-specific cellular components.

How can rec27 antibodies be used to study the MRR complex assembly and DNA binding mechanism?

Rec27 antibodies can be powerful tools for investigating MRR complex formation and DNA binding through several sophisticated methodological approaches:

  • Chromatin immunoprecipitation (ChIP) assays: Rec27 antibodies can be used to identify the genomic loci where the MRR complex binds during meiosis. This approach has revealed that Rec27 predominantly associates with sites poised to become DSB hotspots .

  • Immunoprecipitation followed by Western blotting: To study MRR complex assembly, researchers can use Rec27 antibodies to pull down the protein from meiotic cell extracts and then probe for co-precipitation of Mug20 and Rec25. This technique has been instrumental in determining that the three proteins form a stable complex in vivo and that complex formation is essential for DNA binding activity .

  • Super-resolution microscopy: Using fluorescently labeled Rec27 antibodies, researchers can visualize the spatial organization of the MRR complex along chromosome axes with nanometer precision. This approach has helped demonstrate that Rec27 forms phase-separated condensates with duplex DNA that compact DNA substrates .

  • In vitro reconstitution assays: By combining purified Rec27, Rec25, and Mug20 proteins with DNA substrates in the presence or absence of Rec27 antibodies, researchers can determine how antibody binding affects complex assembly and DNA binding. These experiments have shown that while Rec27 plays the primary role in protein-DNA interactions, it requires complex formation with Rec25 and Mug20 to bind DNA effectively .

  • Fluorescence recovery after photobleaching (FRAP): Using fluorescently labeled Rec27 antibodies in live cell imaging, researchers can study the dynamics of MRR complex assembly and disassembly during meiotic progression.

What are the considerations when using rec27 antibodies to investigate the role of the 5E mutation sites?

When investigating the five critical basic amino acid residues in Rec27 (K28E, R32E, R33E, K35E, and K36E), researchers should consider several methodological aspects:

  • Epitope specificity: Antibodies raised against wild-type Rec27 may have altered binding affinity for the 5E mutant due to the significant change in charge from positive to negative. Circular dichroism (CD) spectroscopy has confirmed that the 5E mutations do not cause severe structural alterations in the MRR complex, suggesting that conformational epitopes should remain largely intact .

  • Immunoblotting considerations: The 5E mutations cause a considerable decrease in electrophoretic mobility compared to wild-type Rec27. Researchers should adjust SDS-PAGE conditions accordingly when using Rec27 antibodies for Western blot detection of the mutant protein .

  • Functional assay design: When using antibodies to study how the 5E mutations affect MRR complex function, it's important to note that these mutations specifically disrupt DNA binding without preventing complex formation. Experimental designs should account for this distinction .

  • Immunoprecipitation efficiency: The 5E mutations may affect antibody recognition if the epitope includes or is near the mutated region. Researchers should validate antibody performance with both wild-type and mutant proteins before conducting extensive studies.

  • Chromatin association studies: Since the 5E mutant MRR complex fails to bind DNA, ChIP assays using Rec27 antibodies will likely show significantly reduced chromatin association. Controls with wild-type protein are essential for proper interpretation of results.

How can researchers use rec27 antibodies to study the CDK-dependent regulation of DSB formation?

To investigate the relationship between CDK activity and Rec27 function in DSB formation, researchers can employ several methodological approaches using rec27 antibodies:

  • Phosphospecific antibody development: Generate antibodies that specifically recognize CDK-phosphorylated forms of Rec27. This approach requires identification of CDK phosphorylation sites on Rec27 and validation of phosphospecificity using phosphatase treatment controls .

  • Temporal analysis of Rec27 phosphorylation: Use phosphospecific Rec27 antibodies to track the timing of Rec27 phosphorylation relative to meiotic S-phase and DSB formation. Studies have shown that inhibition of Cdc2 (the primary CDK in fission yeast) blocks DSB formation, suggesting a potential regulatory role for CDK in activating the MRR complex .

  • Chromatin association dynamics: Employ ChIP assays with Rec27 antibodies to determine how CDK inhibition affects MRR complex localization to chromosomal axes and DSB hotspots. Time course experiments following release from CDK inhibition can provide insights into the kinetics of Rec27 chromatin association .

  • Co-immunoprecipitation studies: Use Rec27 antibodies to pull down the protein from extracts of cells with normal or inhibited CDK activity, then analyze changes in interaction partners that might explain how CDK regulates MRR complex function.

  • Quantitative immunofluorescence: Combine Rec27 antibodies with fluorescence microscopy to quantify changes in Rec27 localization and abundance on meiotic chromosomes under conditions of normal or inhibited CDK activity .

These approaches can help elucidate whether CDK directly phosphorylates Rec27 or regulates its function through intermediate factors.

What are the optimal fixation and permeabilization protocols for immunofluorescence studies with rec27 antibodies?

When conducting immunofluorescence studies with rec27 antibodies in fission yeast, researchers should consider these methodological approaches:

  • Fixation optimization:

    • For nuclear proteins like Rec27, a 15-minute fixation with 3.7% formaldehyde followed by methanol post-fixation typically preserves nuclear architecture while allowing antibody accessibility .

    • Shorter fixation times (5-10 minutes) may be necessary if the epitope is sensitive to over-fixation.

    • Alternative fixatives such as methanol alone (-20°C for 6 minutes) may be preferable if formaldehyde masks the epitope.

  • Permeabilization protocols:

    • For fission yeast cells, enzymatic digestion of the cell wall with zymolyase (1mg/ml for 10-30 minutes) followed by 1% Triton X-100 permeabilization (5 minutes) generally provides good accessibility to nuclear proteins.

    • Detergent concentration and exposure time should be optimized to balance cellular permeabilization and epitope preservation.

  • Buffer considerations:

    • Phosphate-buffered saline (PBS) with 1% BSA is typically used for antibody dilution and washing steps.

    • For phosphospecific Rec27 antibodies, including phosphatase inhibitors (10mM NaF, 1mM Na3VO4) in all buffers is essential to preserve phosphoepitopes.

  • Signal enhancement strategies:

    • Tyramide signal amplification can be employed for low-abundance detection of Rec27.

    • Combining Rec27 antibody staining with fluorescent tags on other MRR complex components can provide valuable co-localization data.

  • Controls:

    • Include rec27 deletion strains as negative controls.

    • Compare staining patterns during vegetative growth versus meiosis (Rec27 is meiosis-specific).

    • Include peptide competition controls to confirm specificity .

These protocols should be systematically optimized for each specific Rec27 antibody to ensure consistent and reliable immunofluorescence results.

What methods are recommended for quantifying rec27 binding to DNA using antibody-based approaches?

For quantitative analysis of Rec27's DNA binding capacity, researchers can utilize several antibody-based methodological approaches:

  • Chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR):

    • This method allows precise quantification of Rec27 enrichment at specific genomic loci.

    • Protocols should include careful optimization of crosslinking conditions, sonication parameters, and antibody concentrations.

    • For comparing wild-type Rec27 with binding-deficient mutants like the 5E variant, normalization to input DNA and appropriate negative controls (such as non-hotspot regions) is crucial .

  • Microscale thermophoresis (MST) with labeled antibodies:

    • MST can measure binding affinities between purified MRR complex and DNA fragments.

    • Rec27 antibodies conjugated to fluorescent dyes can be used to detect and quantify complex formation.

    • This approach is particularly valuable for comparing binding affinities of wild-type versus mutant MRR complexes to various DNA substrates .

  • Electrophoretic mobility shift assay (EMSA) with antibody supershifts:

    • EMSAs have demonstrated that the MRR complex binds DNA, with Rec27 playing the primary role.

    • Adding Rec27 antibodies to the reaction creates a supershift that can confirm complex identity.

    • Quantitative analysis of band intensities can determine binding affinities and the impact of mutations .

  • Single-molecule approaches:

    • Fluorescently labeled Rec27 antibodies can be used in single-molecule pull-down assays to study individual MRR-DNA complexes.

    • Total internal reflection fluorescence (TIRF) microscopy with antibody-labeled components can visualize MRR complex assembly on DNA in real-time.

    • These approaches have revealed that the MRR complex forms phase-separated condensates with duplex DNA .

  • In vitro reconstitution with purified components:

    • Using purified Rec27, Rec25, and Mug20, researchers can systematically analyze how complex formation affects DNA binding.

    • Antibodies against individual components can be used to track their contributions to the assembled complex .

How can rec27 antibodies be used to investigate protein-protein interactions within the MRR complex?

To study protein-protein interactions within the MRR complex, researchers can employ several antibody-based techniques:

  • Co-immunoprecipitation (Co-IP):

    • Using Rec27 antibodies to pull down the protein from meiotic cell extracts, followed by Western blotting for Rec25 and Mug20.

    • Reverse Co-IP with antibodies against Rec25 or Mug20 can confirm the interactions.

    • Varying stringency conditions in the IP buffer can provide insights into the strength of these interactions.

    • This approach has been instrumental in demonstrating that formation of the intact MRR complex is required for DNA binding activity .

  • Proximity ligation assay (PLA):

    • This technique can visualize Rec27's interactions with Rec25 and Mug20 in situ with high sensitivity.

    • By combining antibodies against different components of the MRR complex, researchers can generate fluorescent signals only when proteins are in close proximity (<40 nm).

    • PLA can reveal the spatial and temporal dynamics of MRR complex assembly during meiotic progression.

  • Förster resonance energy transfer (FRET):

    • Using fluorescently labeled antibodies against different MRR components, FRET analysis can provide quantitative measurements of protein-protein proximities.

    • This approach is particularly valuable for studying conformational changes in the complex upon DNA binding.

  • Chemical crosslinking followed by immunoprecipitation:

    • Treating cells with protein crosslinkers before immunoprecipitation with Rec27 antibodies can stabilize transient interactions.

    • Mass spectrometry analysis of the crosslinked products can identify interaction interfaces and potential additional binding partners.

  • Domain-specific antibodies:

    • Generating antibodies against specific domains of Rec27 can help map the regions responsible for interactions with Rec25 and Mug20.

    • Epitope-specific antibodies can be used to block particular interaction surfaces and assess their functional importance .

Research has demonstrated that while Rec27 contains the primary DNA-binding activity, it requires complex formation with Rec25 and Mug20 to bind DNA effectively, highlighting the essential nature of these protein-protein interactions for proper MRR complex function .

What are common challenges when using rec27 antibodies in chromatin immunoprecipitation experiments?

Researchers working with rec27 antibodies in ChIP experiments frequently encounter several methodological challenges:

  • Low signal-to-noise ratio:

    • Rec27's meiosis-specific expression pattern means background signal can dominate in mixed populations.

    • Solution: Synchronize meiotic cultures and harvest cells at the appropriate time point (typically 3-4 hours after meiotic induction) when Rec27 expression peaks .

    • Implement stringent washing conditions and include appropriate negative controls (rec27Δ strains, non-meiotic cells).

  • Epitope masking due to protein-protein interactions:

    • Rec27's incorporation into the MRR complex may obscure antibody epitopes.

    • Solution: Test multiple antibodies targeting different regions of Rec27.

    • Optimize crosslinking conditions to balance preservation of protein-DNA interactions with antibody accessibility.

  • Cell wall digestion efficiency:

    • Fission yeast's tough cell wall can impede antibody access in ChIP protocols.

    • Solution: Carefully optimize zymolyase treatment (concentration and duration) for each experiment.

    • Consider including sorbitol in buffers to stabilize spheroplasts after cell wall digestion.

  • Consistency across meiotic timepoints:

    • Rec27 association with chromatin changes dramatically throughout meiosis.

    • Solution: Include an internal control (such as a constitutively expressed tagged protein) for normalization.

    • Maintain precise timing in meiotic induction protocols to ensure reproducibility.

  • DNA shearing consistency:

    • The condensed nature of meiotic chromatin can lead to variable sonication efficiency.

    • Solution: Carefully optimize sonication parameters for meiotic samples specifically.

    • Implement quality control steps to verify consistent fragmentation (100-500 bp) before proceeding with immunoprecipitation.

  • Cross-reactivity with related proteins:

    • Antibodies may detect related LinE (Linear Element) proteins.

    • Solution: Validate antibody specificity using western blotting on extracts from wild-type and rec27Δ strains.

    • Consider using tagged Rec27 strains and anti-tag antibodies as an alternative approach .

How can researchers distinguish between rec27-specific signals and background in immunofluorescence microscopy?

To maximize specificity and minimize background in immunofluorescence experiments with rec27 antibodies, researchers should implement these methodological strategies:

  • Genetic controls:

    • Always include rec27Δ (deletion) strains as negative controls.

    • Use strains with fluorescently tagged Rec27 as positive controls to compare localization patterns.

    • Employ strains with mutated Rec27 (such as the 5E variant) to distinguish specific from non-specific staining .

  • Signal validation approaches:

    • Perform peptide competition assays: pre-incubate the antibody with excess purified Rec27 protein or immunizing peptide to block specific binding.

    • Compare staining patterns with antibodies targeting other MRR complex components (Rec25, Mug20) to confirm co-localization .

    • Use multiple antibodies targeting different epitopes of Rec27 to verify signal consistency.

  • Technical optimization:

    • Titrate primary antibody concentrations to determine the optimal signal-to-noise ratio.

    • Implement more stringent washing conditions (higher salt concentration, longer wash times) to reduce non-specific binding.

    • Use newer mounting media containing antifade reagents to improve signal stability and reduce autofluorescence.

  • Image acquisition and analysis:

    • Collect z-stack images to capture the full nuclear volume and avoid misleading 2D projections.

    • Employ deconvolution algorithms to improve signal clarity and resolution.

    • Implement quantitative analysis methods that include background subtraction and normalization between samples.

  • Biological context validations:

    • Compare vegetative cells (where Rec27 is not expressed) versus meiotic cells.

    • Track staining patterns across meiotic time courses to confirm expected temporal dynamics.

    • Use dual labeling with markers of meiotic progression (such as antibodies against synaptonemal complex components) to contextualize Rec27 signals .

What are the critical parameters for successful immunoprecipitation of the MRR complex using rec27 antibodies?

Successful immunoprecipitation of the MRR complex requires careful attention to several critical methodological parameters:

  • Cell lysis conditions:

    • Fission yeast cells require efficient disruption of the cell wall, typically using a combination of enzymatic (zymolyase) and mechanical (bead beating) methods.

    • Buffer composition is crucial: 50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate provides a good starting point for preserving the MRR complex .

    • Include protease inhibitors (PMSF, leupeptin, pepstatin) and, if studying phosphorylation, phosphatase inhibitors (sodium fluoride, sodium orthovanadate).

  • Antibody selection and coupling:

    • Polyclonal antibodies often work better than monoclonals for IP due to their recognition of multiple epitopes.

    • Pre-clearing lysates with protein A/G beads alone helps reduce non-specific binding.

    • Direct coupling of antibodies to beads (versus indirect capture) can reduce background from immunoglobulin heavy and light chains in subsequent analyses.

  • Complex stabilization:

    • The MRR complex requires all three components for stability and function; absence of any member weakens the complex .

    • Gentle lysis and handling throughout the protocol helps maintain complex integrity.

    • Consider mild crosslinking (0.1% formaldehyde for 10 minutes) to stabilize the complex before lysis.

  • Washing stringency:

    • Balance between removing non-specific interactions and preserving the MRR complex.

    • A series of washes with increasing stringency (starting with IP buffer, then adding higher salt, and finally including detergent) often works well.

    • Monitor the presence of all three components (Rec27, Rec25, Mug20) throughout optimization to ensure the complex remains intact .

  • Elution conditions:

    • Competitive elution with the immunizing peptide can provide milder conditions than standard SDS elution.

    • If studying DNA interactions, consider nuclease treatment to release DNA-bound complexes.

    • For mass spectrometry applications, on-bead digestion can minimize sample loss and contamination.

  • Validation approaches:

    • Always confirm the presence of all three MRR components in the immunoprecipitate by Western blotting.

    • Include controls such as IgG-only immunoprecipitations and lysates from rec27Δ strains.

    • Consider reciprocal IPs with antibodies against Rec25 or Mug20 to validate interactions .

How can rec27 antibodies contribute to studies on meiotic DSB regulation by CDK activity?

Rec27 antibodies can provide critical insights into the CDK-dependent regulation of meiotic DSB formation through several sophisticated methodological approaches:

  • Phosphorylation-state specific antibodies:

    • Developing antibodies that specifically recognize CDK-phosphorylated forms of Rec27 would allow direct monitoring of its phosphorylation status during meiotic progression.

    • These antibodies can be validated by testing reactivity after treatment with phosphatases or CDK inhibitors like 1-NM-PP1 in the ATP-analog sensitive cdc2-asM17 strain .

    • Western blotting with phospho-specific antibodies across meiotic time courses can reveal the temporal relationship between CDK activity and Rec27 phosphorylation.

  • Chromatin association dynamics:

    • ChIP experiments with Rec27 antibodies in cells with normal or inhibited CDK activity can determine whether CDK regulates Rec27's association with chromosomes.

    • Studies have shown that inhibition of Cdc2 blocks DSB formation, suggesting CDK may regulate the MRR complex directly or indirectly .

    • Time-resolved ChIP following CDK inhibitor washout can track the kinetics of Rec27 re-association with chromatin.

  • Protein interaction networks:

    • Immunoprecipitation with Rec27 antibodies followed by mass spectrometry can identify CDK-dependent changes in the Rec27 interactome.

    • Comparing interacting partners in wild-type cells versus CDK mutants or inhibitor-treated cells can reveal regulatory mechanisms.

    • Particular attention should be paid to interactions with other DSB formation proteins like Rec12 (Spo11 homolog) that might be CDK-regulated.

  • Conformational changes:

    • Limited proteolysis experiments with purified MRR complex, with or without prior CDK treatment, followed by detection with domain-specific Rec27 antibodies can reveal phosphorylation-induced conformational changes.

    • These approaches can determine whether CDK phosphorylation directly alters MRR complex structure or DNA binding properties.

  • Combined genetic and biochemical approaches:

    • Analyzing Rec27 phosphorylation and localization in checkpoint mutants like rad3Δ can separate direct CDK effects from checkpoint-mediated regulation .

    • Rec27 antibodies can be used to monitor protein levels and localization in various genetic backgrounds to dissect regulatory pathways.

These approaches can help elucidate whether CDK directly regulates Rec27 or acts through intermediate factors to control meiotic DSB formation.

What role can rec27 antibodies play in understanding the relationship between chromatin structure and DSB formation?

Rec27 antibodies can be powerful tools for investigating the complex relationship between chromatin structure and DSB formation through these methodological approaches:

  • Genome-wide mapping approaches:

    • ChIP-seq with Rec27 antibodies can generate high-resolution maps of Rec27 binding sites across the genome.

    • Integration with data on chromatin accessibility (ATAC-seq), histone modifications (ChIP-seq for H3K4me3, H3K9me2, etc.), and DSB locations (e.g., by Rec12-oligonucleotide mapping) can reveal chromatin features associated with Rec27 binding and DSB formation.

    • Studies have shown that Rec27 binds to sites poised to be DSB hotspots, suggesting a role in designating break sites .

  • Chromatin conformation analyses:

    • Using Rec27 antibodies in chromosome conformation capture (3C, Hi-C) experiments can identify long-range chromosomal interactions mediated by the MRR complex.

    • These approaches can test the hypothesis that the MRR complex alters chromosome structure by forming phase-separated condensates with duplex DNA that compact DNA substrates .

  • Super-resolution microscopy:

    • Immunofluorescence with Rec27 antibodies, combined with super-resolution microscopy techniques (STORM, PALM), can visualize the nanoscale organization of Rec27 along chromosome axes.

    • Co-labeling with markers of chromatin states can reveal relationships between Rec27 localization and chromatin structure.

    • This approach can test whether the MRR complex forms phase-separated domains in vivo, as suggested by in vitro studies .

  • Chromatin fractionation:

    • Biochemical fractionation of chromatin followed by immunoblotting with Rec27 antibodies can determine which chromatin fractions are enriched for the MRR complex.

    • Comparing wild-type cells with histone modification mutants can reveal dependencies on specific chromatin states.

  • In vitro reconstitution:

    • In vitro binding assays using Rec27 antibodies can assess how the MRR complex interacts with various chromatin templates (naked DNA, nucleosomal arrays, specifically modified nucleosomes).

    • These experiments can directly test how chromatin structure affects MRR binding and function.

  • Genetic interaction studies:

    • Rec27 antibodies can be used to monitor protein levels and localization in various chromatin modifier mutants.

    • These studies can identify genetic interactions between the MRR complex and chromatin remodeling or modification pathways.

How can antibody-based approaches help investigate the dynamics of rec27 localization during meiotic progression?

To study the dynamics of Rec27 localization throughout meiosis, researchers can employ several antibody-based methodological approaches:

  • Time-resolved immunofluorescence microscopy:

    • Using Rec27 antibodies for immunofluorescence in synchronized meiotic cultures, sampled at regular intervals (e.g., every 30 minutes).

    • Co-staining with markers of meiotic progression (e.g., spindle pole body components for staging) provides temporal context.

    • Quantitative image analysis can track changes in Rec27 signal intensity, distribution patterns, and co-localization with other proteins throughout meiosis.

    • This approach has revealed that Rec27 localizes to chromosome axes during meiotic prophase, coinciding with the timing of DSB formation .

  • ChIP time courses:

    • Performing ChIP with Rec27 antibodies at sequential time points during meiotic progression.

    • Analyzing specific loci by qPCR or genome-wide by sequencing can reveal dynamic changes in Rec27 binding patterns.

    • Integration with data on DSB timing can establish the temporal relationship between Rec27 binding and break formation.

  • Live cell imaging with antibody fragments:

    • Using fluorescently labeled recombinant antibody fragments (Fab, scFv) that can penetrate live cells.

    • This approach allows real-time tracking of Rec27 dynamics without the need for genetic tagging.

    • Time-lapse imaging can capture transient interactions and rapid relocalization events.

  • Protein stability and turnover analysis:

    • Immunoblotting with Rec27 antibodies after cycloheximide treatment can determine protein half-life at different meiotic stages.

    • Pulse-chase experiments followed by immunoprecipitation can reveal whether Rec27 is recycled or degraded after DSB formation.

    • These approaches can establish whether changes in localization reflect redistribution or turnover of the protein.

  • Chromatin fractionation across meiotic time points:

    • Biochemical separation of chromatin fractions followed by immunoblotting with Rec27 antibodies.

    • This approach can track changes in the association of Rec27 with different chromatin compartments throughout meiosis.

    • Combined with nuclease sensitivity assays, it can reveal changes in the accessibility of Rec27-bound chromatin.

  • Proximity ligation assays across meiotic stages:

    • Using Rec27 antibodies in combination with antibodies against other meiotic proteins.

    • This approach can map the changing interaction network of Rec27 throughout meiotic progression.

    • Quantification of PLA signals can provide insights into the timing of complex assembly and disassembly.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.